Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes
Cells · 2026
DOI: 10.3390/cells15050451 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Feifei Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre & Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Camperdown, NSW 2050, Australia. Hauptthemen laut MEDLINE: alpha-Synuclein, Neurodegenerative Diseases, Nerve Degeneration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Infectious Disease Society of America, NHMRC Senior Investigator, IDSA Foundation.
Abstract (Originalsprache)
Alpha-synuclein (αSyn) is one of the most abundant proteins in the nervous system and is currently associated with devastating synucleinopathies, yet its biology extends far beyond this. In this review, we suggest that αSyn-driven disease emerges within specific neural circuits through the combined effects of cell-type-specific roles, subcellular environments, post-translational modifications (PTMs), and co-pathology. These interacting and additive dimensions, rather than αSyn alone, generate the pathological diversity, shaping whether pathology manifests as Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), or mixed dementia phenotypes. We integrate recent advances on the physiological roles of αSyn in neurons and glia (astrocytes, oligodendrocytes, and microglia), its compartment-dependent (e.g., synaptic and nuclear) functions, and the molecular transitions (e.g., mediated by pS129) that convert functional assemblies into pathogenic conformers. Building on this foundation, we outline mechanisms through which these factors contribute to disease-specific vulnerability, progression, and clinical heterogeneity. Finally, we highlight how this multidimensional perspective on αSyn biology can inform the development of next-generation biomarkers that support precision therapies across distinct disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Mind Centre & Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Camperdown, NSW 2050, Australia.
ORCID-Profile: Feifei Su, Woojin S Kim, Glenda M Halliday, YuHong Fu
Förderung
- Infectious Disease Society of America
- NHMRC Senior Investigator
- IDSA Foundation
- NHMRC
Zitieren
APA
Su, F., Kim, W. S., Halliday, G. M., & Fu, Y. (2026). Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes. Cells. https://doi.org/10.3390/cells15050451
Vancouver
Su F, Kim WS, Halliday GM, Fu Y. Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes. Cells. 2026. doi:10.3390/cells15050451
BibTeX
@article{Su2026,
author = {Su, Feifei and Kim, Woojin S and Halliday, Glenda M and Fu, YuHong},
title = {Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15050451}
}
EUVIMED